Report / Drug application metadata
EXCEDRIN (MIGRAINE RELIEF)
The application NDA020802 lists 1 product formulation. Its sponsor is HALEON US HOLDINGS. The product details below come from the application record, not a prescribing guide.
Which products are in this application?
EXCEDRIN (MIGRAINE RELIEF)
- Active ingredients
- ACETAMINOPHEN 250MG; ASPIRIN 250MG; CAFFEINE 65MG
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Over-the-counter
- Product number
- 001
How should this information be used?
An application can contain several product versions and a history of submissions. The details shown here do not establish current availability in a particular country or pharmacy, and a listed strength is not a recommended dose. Check the current approved product label for indications, contraindications, warnings and dosing.
This page does not infer a medicine's treatment uses from its name or regulatory status. Application metadata is evidence about the listed product, not evidence that it is suitable for an individual patient.
- Kind
- Drug application metadata
- Identifier
- NDA020802
- Sponsor
- HALEON US HOLDINGS